Legal

Disclaimer — 21+ Research Use Only Terms

Remy Peptides publishes research-use-only reference material for readers aged 21 or older working in an in-vitro laboratory research context. Nothing on this site is medical, veterinary, dosing, or legal advice.

01

Research Use Only; No Human or Veterinary Use

The research compounds described on this site are documented strictly in the context of in-vitro laboratory research purposes only. They are not drugs, dietary supplements, food products, cosmetics, compounded medicines, medical devices, or veterinary preparations.

Nothing described here is intended, marketed, or presented for human or animal consumption, injection, ingestion, topical application, self-experimentation, diagnosis, treatment, prevention, cure, mitigation, or any other form of bodily introduction. This applies to every compound covered in the research library, without exception.

02

21+ Reader Requirement

By accessing the site, the reader confirms that they are:

  • At least 21 years of age
  • A qualified researcher, laboratory professional, science journalist, or other reader consulting this material in a professional research context
  • Reading this material solely for lawful scientific research, analytical reference, quality-control comparison, or laboratory protocol development
  • Not treating this material as guidance for personal use, clinical administration, patient use, animal treatment, or any consumer wellness purpose
  • Aware of and compliant with all applicable local, national, storage, handling, institutional, and professional rules governing research compounds
03

No Medical, Veterinary, or Legal Advice

Nothing on the Remy Peptides website, research articles, lab-results pages, COA records, calculators, search results, email correspondence, social media, or written communications constitutes medical advice, veterinary advice, diagnosis, treatment, cure, prevention, prescribing guidance, legal advice, or regulatory clearance.

No communication from Remy Peptides creates a doctor-patient, veterinarian-client, pharmacist-patient, lawyer-client, clinical, professional advisory, or fiduciary relationship. Scientific and pharmacological information is provided as research context for qualified laboratory users only.

04

No Dosing, Administration, or Self-Experimentation Guidance

Remy Peptides does not provide dosing schedules, administration instructions, injection guidance, titration plans, cycle designs, personal-use protocols, side-effect management, reconstitution guidance for bodily use, or any recommendation about how a person or animal should use any compound.

Any concentration, vial size, batch identifier, mechanism discussion, stability note, or published-study reference appears only for laboratory planning, analytical comparison, or research context. It must not be interpreted as a direction for human or veterinary use.

05

Regulatory Status and Local Law Responsibility

Remy Peptides operates from Pinnacle Building, Al Barsha 1, Dubai, United Arab Emirates. Our editorial framing, labelling references, and published communications are written for in-vitro laboratory research reference only, and are designed to remain within that scope.

Research-use status in the UAE does not guarantee that a compound may be possessed, stored, transferred, tested, or used in another jurisdiction. Readers are solely responsible for confirming applicable law, including controlled-substance rules, sanctions, institutional policies, professional licensing duties, and any permit or end-user documentation requirements.

This disclaimer is a general website disclaimer. It is not legal advice. Readers should consult qualified counsel, compliance officers, or relevant regulators when legal status is uncertain.

06

COA, Testing, and Published Information Limits

Certificate of Analysis reports published in the /coa/ archive and explained in the /lab-results/ hub are reproduced from the issuing laboratory and tied to the batch or sample identified in the report. A COA may support identity, purity, assay, endotoxin, heavy-metal, solvent, sterility, or related analytical findings only where those tests are expressly shown on that report.

COAs, purity figures, assay values, batch IDs, storage notes, images, compound descriptions, and research summaries are not medical-use guarantees, safety guarantees, sterility guarantees for human use, regulatory approvals, or substitutes for the reader’s own qualification, validation, risk assessment, and lawful laboratory controls.

Published information may change as batch records, testing data, law, or third-party source records change. Remy Peptides may correct errors, update pages, or withdraw published material at any time.

07

Third-Party Sources and External Links

The Remy Peptides site references third-party material including peer-reviewed journal articles, clinical trial registry entries, manufacturer datasheets, regulatory databases, and independent peptide testing reports issued by Janoshik Analytical.

References to third parties are provided for research context and verification only. They do not constitute an endorsement of Remy Peptides by those third parties, or an endorsement by Remy Peptides of any third-party claim, product, service, clinical use, or regulatory conclusion.

08

Misuse and Unauthorized Claims

Readers must not advertise, prescribe, administer, recommend, or otherwise present the compounds described here as medicines, supplements, cosmetics, veterinary products, approved therapies, wellness products, weight-loss products, fertility aids, performance products, or consumer-use products.

Remy Peptides authorises no third party to present its published material as a product endorsement, a supply offer, a quality guarantee, or a claim of human or veterinary suitability.

09

Limitation of Liability and Indemnity

To the maximum extent permitted by UAE law, Remy Peptides accepts no liability, in contract, tort, negligence, strict liability, statute, or otherwise, for any consequence arising from misuse, unlawful possession, storage failure, handling error, bodily use, animal use, clinical use, institutional non-compliance, or reliance on site content outside the research-use-only scope.

This site is published free of charge. Remy Peptides receives no payment from readers, and there is no purchase price, order value, or transaction amount against which a claim could be measured. To the maximum extent permitted by UAE law, its total aggregate liability for any claim related to this site, its published content, or any communication is excluded.

The reader agrees to defend, indemnify, and hold harmless Remy Peptides, its owners, staff, contractors, and affiliates from claims, losses, penalties, damages, fees, costs, and expenses arising from the reader’s breach of this disclaimer, misuse of research compounds, unlawful possession, unauthorized representations, or violation of applicable law.

10

Governing Law, Updates, and Contact

This disclaimer, the Terms of Use, and the Privacy Policy are governed by the laws of the United Arab Emirates. Any dispute arising from the use of this site or from communications with Remy Peptides shall be subject to the exclusive jurisdiction of the courts of Dubai, UAE.

Remy Peptides may update this disclaimer without prior notice to reflect changes in law, risk controls, testing practices, or internal editorial and compliance standards. Continued site access after an update constitutes acceptance of the updated disclaimer.

Compliance or legal-status questions may be sent through the verified contact page. Remy Peptides can explain its own research-use-only editorial position, but readers remain responsible for independent legal and institutional review.

Effective Date: 25 July 2026